Sony CRE-C20 vs Yeasound RIC800

The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.